I am utilizing various methods to engineer superior T cells for cancer immunotherapy. These include designing chimeric receptors, altering signaling networks, and introducing mutations. Hopefully these engineered T cells will be able to preferentially expand in vivo, overcome the hostile tumor microenvironment and produce a better therapeutic option for patients. I also manage the flow cytometry core for the Deeley Research Centre, where we have recently acquired two Cytek Aurora instruments and a BD FACS Melody sorter.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.